PDE4 has been well documented as a regulator of inflammation and inhibition of PDE4 has been demonstrated to exert anti-inflammatory effects in diseases including asthma, lung neutrophilia, arthritis, inflammatory bowel disease, multiple sclerosis, osteoporosis, and others [16]. This evidence concerns the gene PDE4A and osteoporosis.